Choosing the right technology for a life sciences website redesign

The platform decision is where a life sciences website redesign is either set up to last or quietly undermined. Chosen against the organization's real content, compliance, and maintenance needs, the technology recedes and the work shows. Chosen by habit or vendor preference, it fights the team on every update. We make this decision last, against evidence, because the right platform is the one that fits the requirements the earlier work surfaced, not the one anyone arrived already favoring.

Decide the platform against requirements, not habit

There is no universally correct platform for a life sciences website, and any recommendation that arrives before the requirements do is a preference wearing the costume of a decision. The platform should answer to what the organization actually needs to publish, review, and maintain. That is why we treat technology selection as a conclusion that the website audit and the content modeling feed, rather than a starting assumption.

We are platform agnostic front- and back-end technologists, enabling enterprise-scale web transformation, and that stance is practical rather than rhetorical. Having no stake in a particular platform is what lets the requirements decide.

Weigh the criteria that actually matter

A handful of criteria carry most of the weight in a life science website redesign. We weigh them explicitly rather than letting a feature list or a demo set the agenda.

• Structured content. Can the platform model pipeline, publications, and data as structured records, and expose them to filtering and sorting, rather than forcing hand-built pages.
• Review and publishing workflow. Can content pass medical, legal, or regulatory review before it goes live, with staging and approval as real steps in the system.
• Data and privacy control. Does the platform give genuine control over consent, tracking, and data handling across the regions the organization serves.
• Accessibility. Does it support building to WCAG 2.1 AA cleanly, or does it fight the standard.
• Hosting and security. Does the hosting and security posture satisfy the organization's IT and vendor review, which on a regulated site is not optional.
• Maintainability. Can the internal team keep the site current without an agency on retainer for every edit.

A platform that scores well on a sales demo and poorly on these is the wrong choice regardless of how the demo felt.

Let the content model lead the platform

The single most important input to the platform decision is how the content is modeled. If the pipeline, publications, and data are going to live as structured content, which is how a credible presentation of pipeline, publications, and data is built, then the platform has to carry structured content well. Choosing the platform first and bending the content to fit it is the reverse of the right order, and it shows up later as pages that are hard to keep current.

Hold compliance and workflow as hard requirements

On a regulated site, review workflow and data control are not features to be traded away for a nicer editor. If content must clear review before publishing, a platform without a workable staging and approval model will push the organization into unsafe habits, publishing around the system because the system is in the way. The compliance requirements designed in during the wireframe stage are the ones the platform has to honor, and we hold them as non-negotiable rather than nice-to-have.

Weigh total cost honestly

Platform cost is more than a license fee. The honest figure includes implementation, the cost of maintaining the site with the internal team you actually have, and the cost of the workflow friction a poor fit creates over years. A platform that is cheaper to license and more expensive to live with is not the economical choice. We weigh the full picture, and we report costs in plain terms so the decision is made on the real number rather than the headline one. Where a figure involves another currency, we convert it to US dollars and note the basis, so nobody is left comparing across currencies.

Make the call, then commit to it

Once the requirements are weighed, the recommendation should be a single, defensible choice with the reasoning attached, not a menu that pushes the decision back to the client. We recommend one platform, show why it fits the requirements better than the alternatives, and name the tradeoffs it carries, so the organization can commit with its eyes open. That clarity is what lets the project move into build and toward launch and measurement without relitigating the foundation.

For the broader context of how a specialist partner approaches a regulated redesign end to end, what to expect from a life science marketing agency sets out the ground, and our work with partners such as CLSI shows the approach in practice.